Russell Investments Group, Ltd.

Position in MLYS — Mineralys Therapeutics, Inc.

CIK 1692234 Seattle, WA

Position in MLYS

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$3,460,101

-$2,052,819 QoQ

Shares Held

128,247

-37.0% QoQ

Ownership

0.145%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#76

of 224 holders

Holding Since

Sep 2023

8 quarters on record

Voting authority Sole 82% Shared 0% None 18%

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,494,413,888 across 308 Biotechnology names. MLYS ranks #65 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	336,990	$167,393,033
2	REGN	Regeneron Pharmaceuticals, Inc.	230,151	$143,508,345
3	RPRX	Royalty Pharma plc	1,694,250	$94,996,587
4	INCY	Incyte Corp	425,616	$48,247,822
5	ALNY	Alnylam Pharmaceuticals, Inc.	158,228	$47,631,369
6	BMRN	Biomarin Pharmaceutical Inc	783,148	$44,811,725
7	LGND	Ligand Pharmaceuticals Inc	120,304	$38,026,888
8	PTCT	Ptc Therapeutics, Inc.	418,025	$34,098,295

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,460,101	128,247	-37.0%	Shares	Defined	2026-08-06
2026-03-31	$5,512,920	203,504	+16.0%	Shares	Defined	2026-05-08
2025-12-31	$6,363,848	175,361	+5272.6%	Shares	Defined	2026-02-17
2025-09-30	$123,770	3,264	+14091.3%	Shares	Defined	2025-11-13
2025-06-30	$311	23	+35.3%	Shares	Defined	2025-08-13
2024-03-31	$219	17	-99.7%	Shares	Defined	2024-05-08
2023-12-31	$49,698	5,779	-43.2%	Shares	Sole	2024-02-05
2023-09-30	$96,811	10,180	—	Shares	Defined	2023-11-13
No filing history on record for this holder in this stock.